A closely watched trial in Chinese patients is raising hope that ivonescimab will outperform Keytruda in a large global study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback